Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13062-020-00282-3 http://scihub22266oqcxt.onion/10.1186/s13062-020-00282-3 33246479!7691955!33246479     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biol+Direct 2020 ; 15 (1): 28 Nephropedia Template TP {{tp|p=33246479|t=2020. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?|pdf=|usr=}}{{33246479}} gab.com Text Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases JO: Biol Direct http://www.kidney.de/pget.php?&tw=1&pmid=33246479 #FOAvip The pandemic of Coronavirus Disease 2019 (COVID-19) presents the world with the medical challenge associated with multifactorial nature of this pathology. Indeed COVID-19 affects several organs and systems and presents diversified clinical picture. COVID-19 affects the brain in many ways including direct infection of neural cells with SARS-CoV-2, severe systemic inflammation which floods the brain with pro-inflammatory agents thus damaging nervous cells, global brain ischaemia linked to a respiratory failure, thromboembolic strokes related to increased intravascular clotting and severe psychological stress. Often the COVID-19 is manifested by neurological and neuropsychiatric symptoms that include dizziness, disturbed sleep, cognitive deficits, delirium, hallucinations and depression. All these indicate the damage to the nervous tissue which may substantially increase the incidence of neurodegenerative diseases and promote dementia. Twit Text FOAVip Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases ????Biol Direct http://www.kidney.de/pget.php?&tw=1&pmid=33246479 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33246479 #FOAvip English Wikipedia <ref>{{Cite pmid|33246479}}</ref> Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? #MMPMID33246479 Verkhratsky A; Li Q; Melino S; Melino G; Shi Y Biol Direct 2020[Nov]; 15 (1): 28 PMID33246479show ga The pandemic of Coronavirus Disease 2019 (COVID-19) presents the world with the medical challenge associated with multifactorial nature of this pathology. Indeed COVID-19 affects several organs and systems and presents diversified clinical picture. COVID-19 affects the brain in many ways including direct infection of neural cells with SARS-CoV-2, severe systemic inflammation which floods the brain with pro-inflammatory agents thus damaging nervous cells, global brain ischaemia linked to a respiratory failure, thromboembolic strokes related to increased intravascular clotting and severe psychological stress. Often the COVID-19 is manifested by neurological and neuropsychiatric symptoms that include dizziness, disturbed sleep, cognitive deficits, delirium, hallucinations and depression. All these indicate the damage to the nervous tissue which may substantially increase the incidence of neurodegenerative diseases and promote dementia. |*Comorbidity[MESH] |*Epidemics[MESH] |*Pandemics[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*complications/*epidemiology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Neurodegenerative Diseases/*epidemiology/*etiology[MESH]Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases(epmc).pdf DeepDyve Pubget Overpricing